20.05.2022 • NewsSolvay

Solvay Invests in Suanfarma Site to Support Natural Ingredients

Solvay is investing in Suanfarma’s manufacturing site in Lisbon, Portugal, run by subsidiary Cipan, to develop its biotechnological capabilities and support the development of natural ingredients used in the food, flavors and fragrance industries. The move is the first of a long-term strategic alliance between the two firms.

“The investment is in line with our newly formed Renewable Materials and Biotechnology growth platform, and will boost our ability to meet our customers' long-term needs and enable the switch to bio-sourced and natural ingredients,” said An Nuyttens, president of Solvay’s aroma & silica global business units.

The transaction is expected to be completed by mid-2023. Solvay did not disclose the size or value of the investment in the Lisbon site.

Headquartered in Madrid, Spain, Suanfarma manufactures and distributes APIs and nutraceuticals. ArchiMed, a private equity group specializing in the healthcare sector, took a majority stake in Suanfarma in November 2021.

On May 3, Solvay launched its Renewable Materials and Biotechnology platform, which is dedicated to developing innovative and sustainable solutions for a range of markets using renewable feedstocks and biotechnology. The Belgian group’s three other growth platforms are Battery Materials, Green Hydrogen and Thermoplastic Composites.

Author: Elaine Burridge, Freelance Journalist

 

Photo by Alisha Mishra
Photo by Alisha Mishra

Company

Suanfarma

C. de Einstein, 8, 28108 Alcobendas
Madrid
Spain

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.